SGO Annual Meeting on Women's Cancer

Keytruda Combo Beneficial ‘Irrespective of PD-L1’ in Endometrial Cancer

March 26th 2024, 9:00pm

Video

Adding Keytruda to chemotherapy improved survival outcomes in patients with endometrial cancer, regardless of their mismatch repair or PD-L1 status.

Second-Line Tivdak ‘Very Beneficial’ in Cervical Cancer

March 25th 2024, 9:00pm

Video

A phase 3 trial determined that Tivdak showed “game-changing results” for certain patients with cervical cancer, an expert told CURE®.

Cold Compression May Prevent Chemo-Induced Neuropathy

April 4th 2023, 7:00pm

Article

Cryocompression was found to be tolerable and effective in preventing chemotherapy-induced peripheral neuropathy in a small study.

Palliative Care Decreases Hospital Readmissions in Ovarian Cancer

March 27th 2023, 9:00pm

Video

Patients with ovarian cancer who utilized palliative care tended to have fewer hospital readmissions than those who did not, according to a recent study.

Intravenous and Direct-to-Abdomen Chemotherapy Plus Avastin Lead to Similar Outcomes in Advanced Ovarian Cancer

March 23rd 2022, 7:00pm

Article

There were no major differences in survival when comparing intravenous and intraperitoneal chemotherapy plus Avastin in patients with advanced ovarian cancer, research shows.

Treatment With Novel Drug Induces Promising Response Rates in Ovarian Cancer Subgroup

March 22nd 2022, 3:00pm

Article

“These results position mirvetuximab soravtansine to become a practice-changing, biomarker-driven, standard-of-care treatment option for patients with (high folate receptor-alpha)-positive, platinum-resistant ovarian cancer,” noted one of the study authors.

Zejula-Avastin Combo Improves Outcomes, With ‘No Impact on Quality of Life’ in High-Risk Ovarian Cancer

March 22nd 2022, 12:30pm

Article

Zejula plus Avastin led to promising progression-free survival rates with no new side effects for patients with newly diagnosed, advanced ovarian cancer.

Preventing Opioid Addiction in Patients With Cancer

March 28th 2018, 7:57pm

Video

Jaron Mark, M.D., a gynecologic oncology fellow at Roswell Park Comprehensive Cancer Center, discusses the opioid crisis, and the steps that his institution is taking to combat potential addiction in women who undergo surgery for gynecologic cancer.

Ask an Expert: How Do PARP Inhibitors Work?

March 27th 2018, 7:41pm

Video

PARP inhibitors are generating a lot of excitement in the field of ovarian cancer. But how, exactly, do they work? CURE spoke with one expert to find out.

Gene Testing Can Help Improve Ovarian Cancer Care and Decision Making

March 26th 2018, 10:02pm

Article

Knowing which kind of therapy works best can help in determining the ideal cancer care for patients.